RedC Biotech Ltd.
Zeev VILF is a skilled business development professional with extensive experience in the biotechnology and medical device sectors. Currently, VILF is involved with RedC Biotech Ltd. as a key player in developing donor-free universal red blood cells aimed at addressing the global transfusion market exceeding $50 billion. VILF also manages international business development for Shiratech-Solutions and co-founded Munich MedTech Regulatory Consulting, providing expertise in medical device certification. Additional roles include business development positions at EZMEMS, Livia, and Geneyx Genomex Ltd., as well as international business development at Nucleon Cyber. VILF holds a Master’s degree in Psychology from FAU Erlangen-Nürnberg and has background education from Tel Aviv University.
This person is not in any teams
This person is not in any offices
RedC Biotech Ltd.
RedC Biotech is enabling unlimited blood transfusions with its proprietary, donor-free, universal red blood cells, for life saving treatments and advanced therapies. RedC Universal Red Blood Cell Transfusions: - One Blood Type Fits All - The universal red blood cells provided by RedC will be a blood type that is suitable for almost every patient and will have the same potency as the currently used red blood cell transfusion - High Quality - Pathogen free, no undesirable blood components, uniform - Donor Free - Eliminating the need for donors, volunteers and seasonal shortages - Low Cost - Assures effective production, will not require additional testing in hospitals - Saves Lives Worldwide - Access and availability provided worldwide – where and when needed